Study of pegInterferon Alfa-2a, Ribavirin, and Daclatasvir (BMS-790052) With or Without BMS-650032 for Participants in Some Hepatitis C Virus Trials
Clinical trial NCT01428063 · COMPLETED
Trial details
- NCT number
- NCT01428063
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-09-01
- Primary completion
- 2014-09-01
- Enrollment
- 276
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.